The Greater Accra Regional Hospital (Ridge) has unveiled a cutting-edge Bone Marrow Transplant (BMT) unit, the first of its kind in Ghana and only the second in Sub-Saharan Africa.
The facility aims to tackle complex health conditions such as leukemia, breast cancer, colon cancer, sickle cell disease, arthritis, and various neurological disorders.
The BMT unit, inaugurated yesterday in Accra by Dr. Pradeep V. Mahajan, Chairman and Managing Director of STRRX Bioscience Solutions PVT LTD, promises revolutionary advancements in regenerative medicine and precision healthcare.
Transforming Patient Care
Speaking at the launch, Dr. Mahajan highlighted the transformative nature of the facility, which introduces advanced medical technologies comparable to global standards at accessible costs.
“This facility is not just a milestone for Ghana but a step forward for Sub-Saharan Africa.
We are introducing technologies that will not only treat life-threatening conditions but also eliminate the need for repeated surgeries through joint regeneration,” he stated.
Dr. Mahajan explained that the unit employs regenerative techniques allowing joints to heal naturally without surgery, cuts, or anesthesia, ensuring patients can maintain healthy joints for life.
Additionally, the unit will provide care for children with neurological conditions such as Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Cerebral Palsy, Epilepsy, and Down Syndrome.
“This center offers hope for families across West Africa, presenting innovative solutions to challenges that were once insurmountable,” Dr. Mahajan added.
The facility’s focus on precision medicine further ensures that treatments are tailored to individual patient needs rather than generic protocols, offering a personalized approach to healthcare.
A Hub for Research and Training
Prof. George Awuku-Asare, a leading scientist at the unit, emphasized the facility’s potential to position Ghana as a regional hub for medical research and professional training.
“This facility is not just about treatment; it’s about capacity building.
It will serve as a training ground for African scientists and medical professionals, helping to retain talent within the continent,” Prof. Awuku-Asare noted.
The BMT unit will also advance research into stem cell therapy, ensuring the growth and infusion of healthy cells to regenerate damaged tissues.
This integration of therapeutic, regenerative, and cosmetic applications sets the stage for further innovations in healthcare.
Reducing Overseas Dependency
The establishment of the BMT unit represents a significant step toward reducing Ghana’s reliance on overseas treatment for critical medical conditions.
It is expected to attract patients from across West Africa and beyond, solidifying Ghana’s position as a leader in advanced medical care.
“This is a game-changer for Ghana’s healthcare landscape,” Dr. Mahajan remarked, adding that the facility aims to improve the lives of patients while advancing scientific discovery in the region.
The BMT unit is already operational, with experts dedicated to delivering cutting-edge care and driving medical breakthroughs.
This development marks a milestone in Ghana’s medical infrastructure, offering hope to patients and redefining healthcare possibilities in the region
